Trials / Unknown
UnknownNCT01249053
Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- All
- Age
- 25 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Optic atrophy type 1(OPA1) is a nuclear dynamin-related GTPase, targeted to the inner mitochondrial membrane, which plays a role in mitochondrial fusion. Mitochondria fusion is associated with process of apoptosis. . OPA1 plays an important role in the mitochondrial bioenergetics and mitochondrial networks. The changes in mitochondrial shape and mitochondrial bioenergetics may be cause of the disease. In this study, we investigate the expression of OPA1 in lung adenocarcinoma (LADC) cells and tissue.
Conditions
Timeline
- Start date
- 2010-08-01
- First posted
- 2010-11-29
- Last updated
- 2010-11-29
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01249053. Inclusion in this directory is not an endorsement.